☰

Rupert Schmidt-Ullrich - Publications

Affiliations: 
Virginia Commonwealth University, Richmond, VA, United States 
Area:
Molecular Biology, Cell Biology, Medical Biophysics, Oncology
Tree Info Similar researchers PubMed Report error

59 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2006 Contessa JN, Abell A, Valerie K, Lin PS, Schmidt-Ullrich RK. ErbB receptor tyrosine kinase network inhibition radiosensitizes carcinoma cells. International Journal of Radiation Oncology, Biology, Physics. 65: 851-8. PMID 16751066 DOI: 10.1016/J.Ijrobp.2006.02.025  0.625
2006 Sakthi N, Keall P, Mihaylov I, Wu Q, Wu Y, Williamson JF, Schmidt-Ullrich R, Siebers JV. Monte Carlo-based dosimetry of head-and-neck patients treated with SIB-IMRT. International Journal of Radiation Oncology, Biology, Physics. 64: 968-77. PMID 16458782 DOI: 10.1016/J.Ijrobp.2005.09.049  0.319
2006 Contessa JN, Abell A, Mikkelsen RB, Valerie K, Schmidt-Ullrich RK. Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation. Breast Cancer Research and Treatment. 95: 17-27. PMID 16267617 DOI: 10.1007/S10549-005-9023-9  0.636
2004 Lammering G, Hewit TH, Holmes M, Valerie K, Hawkins W, Lin PS, Mikkelsen RB, Schmidt-Ullrich RK. Inhibition of the type III epidermal growth factor receptor variant mutant receptor by dominant-negative EGFR-CD533 enhances malignant glioma cell radiosensitivity. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 6732-43. PMID 15475464 DOI: 10.1158/1078-0432.Ccr-04-0393  0.332
2004 Lammering G, Valerie K, Lin PS, Hewit TH, Schmidt-Ullrich RK. Radiation-induced activation of a common variant of EGFR confers enhanced radioresistance. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 72: 267-73. PMID 15450724 DOI: 10.1016/J.Radonc.2004.07.004  0.341
2004 Lauve A, Morris M, Schmidt-Ullrich R, Wu Q, Mohan R, Abayomi O, Buck D, Holdford D, Dawson K, Dinardo L, Reiter E. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results. International Journal of Radiation Oncology, Biology, Physics. 60: 374-87. PMID 15380569 DOI: 10.1016/J.Ijrobp.2004.03.010  0.369
2003 Lammering G, Hewit TH, Valerie K, Lin PS, Contessa JN, Schmidt-Ullrich RK. Anti-erbB receptor strategy as a gene therapeutic intervention to improve radiotherapy in malignant human tumours. International Journal of Radiation Biology. 79: 561-8. PMID 14530165 DOI: 10.1080/0955300031000102632  0.593
2003 Schmidt-Ullrich RK, Contessa JN, Lammering G, Amorino G, Lin PS. ERBB receptor tyrosine kinases and cellular radiation responses. Oncogene. 22: 5855-65. PMID 12947392 DOI: 10.1038/Sj.Onc.1206698  0.646
2003 Lammering G, Hewit TH, Valerie K, Contessa JN, Amorino GP, Dent P, Schmidt-Ullrich RK. EGFRvIII-mediated radioresistance through a strong cytoprotective response. Oncogene. 22: 5545-53. PMID 12944901 DOI: 10.1038/Sj.Onc.1206788  0.66
2003 Wu Q, Mohan R, Morris M, Lauve A, Schmidt-Ullrich R. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas. I: dosimetric results. International Journal of Radiation Oncology, Biology, Physics. 56: 573-85. PMID 12738335 DOI: 10.1016/S0360-3016(02)04617-5  0.343
2003 Dent P, Yacoub A, Contessa J, Caron R, Amorino G, Valerie K, Hagan MP, Grant S, Schmidt-Ullrich R. Stress and radiation-induced activation of multiple intracellular signaling pathways. Radiation Research. 159: 283-300. PMID 12600231 DOI: 10.1667/0033-7587(2003)159[0283:Sariao]2.0.Co;2  0.636
2003 Lammering G, Hewitt T, Contessa J, Valerie K, Lin P, Mikkelsen R, Schmitt G, Schmidt-Ullrich R. 705 A naturally occurring type III variant mutant EGF receptor confers a strong cytoprotective response to ionizing radiation European Journal of Cancer Supplements. 1: S212. DOI: 10.1016/S1359-6349(03)90736-1  0.35
2003 Lauve A, Morris M, Schmidt-Ullrich R, Wu Y, Wu Q, Tong S, Johnson C, Abayomi O, Buck D, Holdford D, Dawson K, Mohan R. A phase I trial using a parotid-sparing, accelerated Intensity-Modulated Radiotherapy (IMRT) regimen to treat locally advanced head and neck squamous cell carcinoma International Journal of Radiation Oncology*Biology*Physics. 57: S302-S303. DOI: 10.1016/S0360-3016(03)01167-2  0.318
2002 Amorino GP, Hamilton VM, Valerie K, Dent P, Lammering G, Schmidt-Ullrich RK. Epidermal growth factor receptor dependence of radiation-induced transcription factor activation in human breast carcinoma cells. Molecular Biology of the Cell. 13: 2233-44. PMID 12134064 DOI: 10.1091/Mbc.01-12-0572  0.351
2002 Contessa JN, Hampton J, Lammering G, Mikkelsen RB, Dent P, Valerie K, Schmidt-Ullrich RK. Ionizing radiation activates Erb-B receptor dependent Akt and p70 S6 kinase signaling in carcinoma cells. Oncogene. 21: 4032-41. PMID 12037685 DOI: 10.1038/Sj.Onc.1205500  0.62
2002 Wu Q, Mohan R, Niemierko A, Schmidt-Ullrich R. Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose. International Journal of Radiation Oncology, Biology, Physics. 52: 224-35. PMID 11777642 DOI: 10.1016/S0360-3016(01)02585-8  0.302
2002 Contessa J, Abell A, Lammering G, Hewit T, Valerie K, Schmidt-Ullrich R. EGRF-CD533 acts as a PAN-ERBB receptor tyrosine kinase inhibitor International Journal of Radiation Oncology*Biology*Physics. 54: 175-176. DOI: 10.1016/S0360-3016(02)03361-8  0.577
2001 Lammering G, Lin PS, Contessa JN, Hampton JL, Valerie K, Schmidt-Ullrich RK. Adenovirus-mediated overexpression of dominant negative epidermal growth factor receptor-CD533 as a gene therapeutic approach radiosensitizes human carcinoma and malignant glioma cells. International Journal of Radiation Oncology, Biology, Physics. 51: 775-84. PMID 11697324 DOI: 10.1016/S0360-3016(01)01714-X  0.639
2001 Qiao L, Studer E, Leach K, McKinstry R, Gupta S, Decker R, Kukreja R, Valerie K, Nagarkatti P, El Deiry W, Molkentin J, Schmidt-Ullrich R, Fisher PB, Grant S, Hylemon PB, et al. Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: Inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis Molecular Biology of the Cell. 12: 2629-2645. PMID 11553704 DOI: 10.1091/Mbc.12.9.2629  0.375
2001 Lammering G, Hewit TH, Hawkins WT, Contessa JN, Reardon DB, Lin PS, Valerie K, Dent P, Mikkelsen RB, Schmidt-Ullrich RK. Epidermal growth factor receptor as a genetic therapy target for carcinoma cell radiosensitization. Journal of the National Cancer Institute. 93: 921-9. PMID 11416113 DOI: 10.1093/Jnci/93.12.921  0.658
2001 Dent P, Logsdon C, Nicke B, Valerie K, Farnsworth J, Schmidt-Ullrich R, Reardon DB. Recombinant adenoviral expression of dominant-negative Ras N17 blocking radiation-induced activation of mitogen-activated protein kinase pathway. Methods in Enzymology. 333: 28-37. PMID 11400343 DOI: 10.1016/S0076-6879(01)33041-0  0.422
2001 Bowers G, Reardon D, Hewitt T, Dent P, Mikkelsen RB, Valerie K, Lammering G, Amir C, Schmidt-Ullrich RK. The relative role of ErbB1-4 receptor tyrosine kinases in radiation signal transduction responses of human carcinoma cells Oncogene. 20: 1388-1397. PMID 11313882 DOI: 10.1038/Sj.Onc.1204255  0.37
2001 Lammering G, Valerie K, Lin PS, Mikkelsen RB, Contessa JN, Feden JP, Farnsworth J, Dent P, Schmidt-Ullrich RK. Radiosensitization of malignant glioma cells through overexpression of dominant-negative epidermal growth factor receptor. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 7: 682-90. PMID 11297265  0.653
2001 Wu Q, Mohan R, Morris M, Tong S, Schmidt-Ullrich R. Simultaneous integrated boost IMRT of advanced head and neck squamous cell carcinomas using dynamic multi-leaf collimators International Journal of Radiation Oncology*Biology*Physics. 51: 180. DOI: 10.1016/S0360-3016(01)02150-2  0.317
2001 Buck D, Morris M, Schmidt-Ullrich R, Johnson C, Amir C, Huang D. Quantitation of acute and late toxicities of a concomitant-boost thrice-daily dose escalation radiotherapy regimen for advanced head and neck squamous cell carcinomas International Journal of Radiation Oncology*Biology*Physics. 51: 179. DOI: 10.1016/S0360-3016(01)02148-4  0.343
2001 Lammering G, Hewit T, Contessa J, Hawkins W, Lin P, Valerie K, Mikkelsen R, Dent P, Schmidt-Ullrich R. EGFR and its mutant EGFRvIII as modulators of tumor cell radiosensitivity International Journal of Radiation Oncology*Biology*Physics. 51: 103. DOI: 10.1016/S0360-3016(01)02012-0  0.637
2000 Morris MM, Schmidt-Ullrich R, Johnson CR. Advances in radiotherapy for carcinoma of the head and neck Surgical Oncology Clinics of North America. 9: 563-575. PMID 10853142 DOI: 10.1016/S1055-3207(18)30140-6  0.32
2000 Schmidt-Ullrich R. Local tumor control and survival: Clinical evidence and tumor biologic basis Surgical Oncology Clinics of North America. 9: 401-414. PMID 10853133 DOI: 10.1016/S1055-3207(18)30131-5  0.31
2000 Mohan R, Wu Q, Manning M, Schmidt-Ullrich R. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers International Journal of Radiation Oncology Biology Physics. 46: 619-630. PMID 10701741 DOI: 10.1016/S0360-3016(99)00438-1  0.311
2000 Wu Q, Manning M, Schmidt-Ullrich R, Mohan R. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: A treatment design study International Journal of Radiation Oncology Biology Physics. 46: 195-205. PMID 10656393 DOI: 10.1016/S0360-3016(99)00304-1  0.319
2000 Lammering G, Valerie K, Lin P, Mikkelsen R, Hewit T, Schmidt-Ullrich R. Radiosensitization of malignant glioma cells through overexpression of dominant-negative EGFR-CD533 International Journal of Radiation Oncology*Biology*Physics. 48: 246-247. DOI: 10.1016/S0360-3016(00)80289-8  0.374
1999 Schmidt-Ullrich RK, Contessa JN, Dent P, Mikkelsen RB, Valerie K, Reardon DB, Bowers G, Lin PS. Molecular mechanisms of radiation-induced accelerated repopulation. Radiation Oncology Investigations. 7: 321-30. PMID 10644055 DOI: 10.1002/(Sici)1520-6823(1999)7:6<321::Aid-Roi2>3.0.Co;2-Q  0.562
1999 Park JS, Carter S, Reardon DB, Schmidt-Ullrich R, Dent P, Fisher PB. Roles for basal and stimulated p21(Cip-1/WAF1/MDA6) expression and mitogen-activated protein kinase signaling in radiation-induced cell cycle checkpoint control in carcinoma cells Molecular Biology of the Cell. 10: 4231-4246. PMID 10588655 DOI: 10.1091/Mbc.10.12.4231  0.41
1999 Todd DG, Mikkelsen RB, Rorrer WK, Valerie K, Schmidt-Ullrich RK. Ionizing radiation stimulates existing signal transduction pathways involving the activation of epidermal growth factor receptor and erbb-3, and changes of intracellular calcium in a431 human squamous carcinoma cells Journal of Receptor and Signal Transduction Research. 19: 885-908. PMID 10533979 DOI: 10.3109/10799899909038430  0.34
1999 Reardon DB, Contessa JN, Mikkelsen RB, Valerie K, Amir C, Dent P, Schmidt-Ullrich RK. Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activation and enhance radiation toxicity of human mammary carcinoma cells. Oncogene. 18: 4756-66. PMID 10467423 DOI: 10.1038/Sj.Onc.1202849  0.659
1999 Dent P, Reardon DB, Park JS, Bowers G, Logsdon C, Valerie K, Schmidt-Ullrich R. Radiation-induced release of transforming growth factor α activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced cell death Molecular Biology of the Cell. 10: 2493-2506. PMID 10436007 DOI: 10.1091/Mbc.10.8.2493  0.461
1999 Contessa JN, Reardon DB, Todd D, Dent P, Mikkelsen RB, Valerie K, Bowers GD, Schmidt-Ullrich RK. The inducible expression of dominant-negative epidermal growth factor receptor-CD533 results in radiosensitization of human mammary carcinoma cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 5: 405-11. PMID 10037190  0.656
1999 Clay L, Johnson C, Morris M, Schmidt-Ullrich R, Amir C. 2185 Concomitant boost accelerated superfractionated radiotherapy for advanced squamous cell carcinoma of the head and neck: An updated analysis of outcomes International Journal of Radiation Oncology*Biology*Physics. 45: 373. DOI: 10.1016/S0360-3016(99)90454-6  0.329
1999 Schmidt-ullrich R, Bowers G, Dent P, Reardon D, Contessa J, Valerie K. 29 ERBB receptor tyrosine kinases as determinants of cytoprotective and cytotoxic radiation responses of carcinoma cells International Journal of Radiation Oncology*Biology*Physics. 45: 161-162. DOI: 10.1016/S0360-3016(99)90047-0  0.641
1998 Carter S, Auer KL, Reardon DB, Birrer M, Fisher PB, Valerie K, Schmidt-Ullrich R, Mikkelsen R, Dent P. Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose ionizing radiation in A431 human squamous carcinoma cells Oncogene. 16: 2787-2796. PMID 9652746 DOI: 10.1038/Sj.Onc.1201802  0.419
1998 Johnson CR, Silverman LN, Clay LB, Schmidt-Ullrich R. Radiotherapeutic management of bulky cervical lymphadenopathy in squamous cell carcinoma of the head and neck: is postradiotherapy neck dissection necessary? Radiation Oncology Investigations. 6: 52-7. PMID 9503489 DOI: 10.1002/(Sici)1520-6823(1998)6:1<52::Aid-Roi6>3.0.Co;2-H  0.301
1997 Wazer DE, Kramer B, Schmid C, Ruthazer R, Ulin K, Schmidt-Ullrich R. Factors determining outcome in patients treated with interstitial implantation as a radiation boost for breast conservation therapy International Journal of Radiation Oncology Biology Physics. 39: 381-393. PMID 9308942 DOI: 10.1016/S0360-3016(97)00325-8  0.31
1997 Schmidt-Ullrich RK, Mikkelsen RB, Dent P, Todd DG, Valerie K, Kavanagh BD, Contessa JN, Rorrer WK, Chen PB. Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation. Oncogene. 15: 1191-7. PMID 9294612 DOI: 10.1038/Sj.Onc.1201275  0.64
1996 Schmidt-Ullrich RK, Valerie K, Fogleman PB, Walters J. Radiation-induced autophosphorylation of epidermal growth factor receptor in human malignant mammary and squamous epithelial cells Radiation Research. 145: 81-85. PMID 8532841 DOI: 10.2307/3579199  0.332
1996 Schmidt-Ullrich R, Mikkelsen R, Valerie K, Todd D, Kavanagh B, Contessa J, Rorrer K, Chen P. 134 Molecular mechanisms of radiation-induced cell proliferation in human carcinoma cells International Journal of Radiation Oncology*Biology*Physics. 36: 225. DOI: 10.1016/S0360-3016(97)85475-2  0.605
1995 Kavanagh BD, Lin PS, Chen P, Schmidt-Ullrich RK. Radiation-Induced Enhanced Proliferation of Human Squamous Cancer Cells in Vitro: A Release from Inhibition by Epidermal Growth Factor Clinical Cancer Research. 1: 1557-1562. PMID 9815956  0.32
1995 Arthur D, Kaufman N, Schmidt-Ullrich R, Kavanagh B, Simpson P, Hill M, Ali M. Heuristically derived tumor burden score as a prognostic factor for stage IIIB carcinoma of the cervix International Journal of Radiation Oncology, Biology, Physics. 31: 743-751. PMID 7860385 DOI: 10.1016/0360-3016(94)00482-X  0.312
1995 Schmidt-Ullrich R, Valerie K, Mikkelsen R, Todd D, Walters J, Saady M. 1023 Epidermal growth factor-receptor and radiation-induced signal transduction in human mammary and squamous carcinoma cells International Journal of Radiation Oncology*Biology*Physics. 32: 234. DOI: 10.1016/0360-3016(95)97848-U  0.436
1993 Johnson CR, Huang DT, Schmidt-Ullrich R. The equivalence of definitive radiotherapy with combined surgery and postoperative radiotherapy for advanced squamous cell carcinoma of the oropharynx International Journal of Radiation Oncology*Biology*Physics. 27: 248-249. DOI: 10.1016/0360-3016(93)90825-G  0.321
1992 Wazer DE, DiPetrillo T, Schmidt-Ullrich R, Weld L, Smith TJ, Marchant DJ, Robert NJ. Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma Journal of Clinical Oncology. 10: 356-363. PMID 1445509 DOI: 10.1200/Jco.1992.10.3.356  0.313
1992 Schmidt-Ullrich R. Wednesday, November 11, 1992 7:15 – 8:45 a.m.Biological radiation response modifiers International Journal of Radiation Oncology Biology Physics. 24. DOI: 10.1016/0360-3016(92)90102-N  0.306
1992 Schmidt-Ullrich R. Biological radiation response modifiers International Journal of Radiation Oncology*Biology*Physics. 24: 105. DOI: 10.1016/0360-3016(90)90610-V  0.344
1991 Mikkelsen RB, Stedman T, Schmidt-Ullrich R, Lin PS. Effects of tamoxifen and protein kinase C inhibitors on hyperthermic cell killing International Journal of Radiation Oncology, Biology, Physics. 20: 1039-1045. PMID 2022504 DOI: 10.1016/0360-3016(91)90202-F  0.309
1991 Wazer DE, Joyce M, Solares G, Schmidt-Ullrich R. Proliferative inhibition of human breast carcinoma cells by high concentration estradiol does not alter radiosensitivity Breast Cancer Research and Treatment. 18: 141-148. PMID 1756256 DOI: 10.1007/Bf01990029  0.321
1989 Schmidt-Ullrich R, Wazer DE, Tercilla O, Safaii H, Marchant DJ, Smith TJ, Homer MA, Robert NJ. Tumor margin assessment as a guide to optimal conservation surgery and irradiation in early stage breast carcinoma. International Journal of Radiation Oncology, Biology, Physics. 17: 733-8. PMID 2777663 DOI: 10.1016/0360-3016(89)90059-X  0.327
1989 Wazer DE, Tercilla OF, Lin PS, Schmidt-Ullrich R. Modulation in the radiosensitivity of MCF-7 human breast carcinoma cells by 17B-estradiol and tamoxifen British Journal of Radiology. 62: 1079-1083. PMID 2605455 DOI: 10.1259/0007-1285-62-744-1079  0.314
1987 Wazer DE, Tercilla O, Lin P, Schmidt-Ullrich R. Decreased radiosensitivity of MCF-7 human breast carcinoma cells after exposure to the antiestrogen tamoxifen International Journal of Radiation Oncology*Biology*Physics. 13: 112. DOI: 10.1016/0360-3016(87)91066-2  0.307
1986 Schmidt-Ullrich R, Lin PS, Mikkelsen RB, Monroe MM. Proliferative rates of cloned malignant mammary epithelial cells as a measure of clonal heterogeneity in human breast carcinomas. Journal of the National Cancer Institute. 77: 1001-11. PMID 3022054 DOI: 10.1093/Jnci/77.5.1001  0.342
1986 Kelly K, Boldman G, Lawn-Tsao L, Nu A, Schmidt-Ullrich R. Carcinomas of the oral tongue and floor of mouth. Radiation therapy results with external beam and interstitial implantation International Journal of Radiation Oncology*Biology*Physics. 12: 142. DOI: 10.1016/0360-3016(86)90601-2  0.328
Show low-probability matches.